Methane intestinal production and poor metabolic control in type i diabetes complicated by autonomic neuropathy

Minerva Endocrinologica

Volumn 39, Issue 3, 2014, Pages 201-207

  Cesario, V ^a   Di Rienzo, T A ^a   Campanale, M ^a   D'Angelo, G ^a   Barbaro, F ^a   Gigante, G ^a   Vitale, G ^a   Scavone, G ^a   Pitocco, D ^a   Gasbarrini, A ^a   Ojetti, V ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Blood glucose; Diabetes mellitus, type 1; Metabolism

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROGEN; INSULIN; LACTULOSE; METHANE; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTONOMIC NEUROPATHY; BACTERIAL OVERGROWTH; BREATH ANALYSIS; CLINICAL ARTICLE; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE DURATION; ERADICATION THERAPY; EVALUATION STUDY; EXCRETION; FEMALE; GASTROINTESTINAL TRACT; GLYCEMIC CONTROL; HEART RATE; HUMAN; HYPERPNEA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTESTINE FUNCTION; MALE; METABOLIC REGULATION; METHANE PRODUCTION; STANDING; VALSALVA MANEUVER; ANAEROBIC BACTERIUM; BIOSYNTHESIS; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIAGNOSTIC USE; DOSE RESPONSE; DRUG EFFECTS; FERMENTATION; GASTROINTESTINAL MOTILITY; INNERVATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SMALL INTESTINE; STOMACH EMPTYING; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BREATH TESTS; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERMENTATION; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INTESTINE, SMALL; LACTULOSE; MALE; METHANE; METRONIDAZOLE; MIDDLE AGED; YOUNG ADULT;

EID: 84913535407     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001;96:71-6.
2. Bjelakovic G, Nagorni A, Stamenkovic I. Diabetes mellitus and digestive disorders. Acta Fac Med Naiss 2005;22:43-50.
3. Report and recommendations of the San Antonio Conference on diabetic neuropathy (Consensus Statement). Diabetes 1988;37:1000-4.
4. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984;7:447-53.
5. Ewing DJ. Cardiovascular reflexes and autonomic neuropathy. Clin Sei Mol Med 1978;55:321-7.
6. Clarke BF, Ewing DJ, Campbell IW. Diabetic autonomic neuropathy. Diabetologia 1979;17:195-212.
7. Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes. The role of autonomic neuropathy. Postgrad Med J 1991;67:991-3.
8. Werth B, Meyer-Wyee B, Spinas GA, Drewe J, Beg-linger C. Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy. Gut 1992;33:1199-203.
9. Mearin F, Malagelada JR. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995;7:717-23.
10. Von der Ohe R. Diarrhoea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995;7:730-6.
11. Wald A. Incontinence and anorectal dysfunction in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995;7:737-9.
12. Jones KL, Horowitz M, Berry M, et al. The blood glucose concentration influences postprandial fullness in IDDM. Diabetes Care 1997;20:114-6.
13. Russo A, Botten R, Kong MF, Chapman IM, Fraser RJ, Horowitz M et al. Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med 2004;21:176-82.
14. Spengler U, Stellaard F, Ruckdeschel G, Scheurlen C, Kruis W. Small intestinal transit, bacterial growth, and bowel habits in diabetes mellitus. Pancreas 1989;4:65-70.
15. Roza AM, Edmiston CE Jr, Frantzides C, Moore GH, Nowak TV, Johnson CP et al. Untreated diabetes mellitus promotes intestinal microbial overgrowth. Am J Surg 1992;163:417-21.
16. Virally-Monod M, Tielmans D, Kevorkian JP, Bouhnik Y, Flourie B, Porokhov B et al. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab 1998;24:530-6.
17. Cuoco L, Montalto M, Jorizzo RA, Santarelli L, Arancio F, Cammarota G et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 2002;49:1582-6.
18. Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther 2011;13:1115-20.
19. Ojetti Vi, Pitocco D, Scarpellini E, Zaccardi F, Scalda-ferri F, Gigante G et al. Small bowel bacterial overgrowth and type 1 diabetes. Eur Rev Med Pharmacol Sei 2009;13:419-23.
20. Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 2007;25:237-40.
21. 1, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90.
22. Vanderhoof JA, Young RJ. Etiology and pathogenesis of bacterial overgrowth. Clinical manifestations and diagnosis of bacterial overgrowth. Treatment of bacterial overgrowth. UpToDate online, vol 18.1; Wellesley, 2010 [Internet]. Available from: http://www.uptodate. com [cited 2014, Apr 28].
23. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009;29(Suppl l):l-49
24. Levitt MD, Bond JH. Volume, composition, and source of intestinal gas. Gastroenterology 1970;59:921-9.
25. Bond JH, Engel RR, Levitt MD. Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med 1971;133:572-88.
26. Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sei 1987;32:267-71.
27. Flatz G, Czeizel A, Métneki J, Flatz SD, Kiihnau W, Jahn D. Pulmonary hydrogen and methane excretion following ingestion of an unabsorbable carbohydrate: a study of twins. J Pediatr Gastroenterol Nutr 1985;4:936-41.
28. Cloarec D, Bornet F, Gouilloud S, Barry JL, Salim B, Galmiche JP. Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status. Gut 1990;31:300-4.
29. McKay LF, Eastwood MA, Brydon WG. Methane excretion in man-a study of breath, flatus, and faeces. Gut 1985;26:69-74.
30. Sahakian AB, Jee SR, Pimentel M. Methane and the gastrointestinal tract. Dig Dis Sei 2010;55:2135-43.
31. Roccarina D, Lauritano EC, Gabrielli M, Franceschi F, Ojetti V, Gasbarrini A. The role of methane in intestinal diseases. Am J Gastroenterol 2010;105:1250-6.
32. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982;285:916-8.
33. Lee KM, Paik CN, Chung WC, Yang JM, Choi MG. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol 2013;25:726-32.
34. Patterson CC, Dahlquist G, Soltész G, Green A; EU-RODIAB ACE Study Group. Europe and Diabetes. Is childhood onset Type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 2001;4:9-16.
35. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes-the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008;57:2555-62.
36. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut micro-biota in health and disease. Physiol Rev 2010;90:859-904.
37. Florin TH, Zhu G, Kirk KM, Martin NG. Shared and unique environmental factors determine the ecology of methanogens in humans and rats. Am J Gastroenterol 2000;95:2872-9.
38. Flourie B, Etanchaud F, Florent C, Pellier P, Bouhnik Y, Rambaud JC. Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates. Gut 1990;31:684-5.
39. Jones WJ, Nagle DP, Whitman WB. Methanogens and the diversity of archaebacteria. Microbiol Rev 1987;51:135-77.
40. Miller TL, Wolin MJ. Enumeration of Methanobre-vibacter smithii in human feces. Arch Microbiol 1982;131:14-8.
41. Miller TL, Wolin MJ, Conway de Macario E, Macario AJ. Isolation of Methanobrevibacter smithii from human feces. Appl Environ Microbiol 1982;43:227-32.
42. Nottingham PM, Hungate RE. Isolation of methanogen-ic bacteria from feces of man. J Bacteriol 1968;96:2178-9.
43. McKay LF, Holbrook WP, Eastwood MA. Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol Microbiol Immunol Scand [B] 1982;90:257-60.
44. Mathur R, Amichai M, Chua KS, Mirocha J, Barlow GM, Pimentel M. Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab 2013;98:E698-E702.
45. Basseri RJ, Basseri B, Pimentel M, Chong K, Youdim A, Low K et al. Intestinal methane production in obese individuals is associated with a higher body mass index. Gastroenterol Hepatol (N Y) 2012;8:22-8.
46. Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host-archal-bacterial mutualism. Proc Natl Acad Sei USA 2006;103:10011-6.
47. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005;21:985-92.
48. Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 18:1107-12.